"Optimizing the bioinks for islet tissue engineering by using a customi" by Narangerel Gantumur
Type-1 diabetes (T1D) is a chronic metabolic autoimmune disease where the patient's immune system destroys insulin-producing β-cells in the islet of Langerhans. The current treatment option is through frequent administration of exogenous insulin, where the patients must closely monitor the dosage. Patients often need islet transplantation when the β-cell destruction worsens, and the body cannot utilize exogenously administrated insulin. Islet transplantation is a form of cell therapy that...
Translational Research Initiative For Cell Engineering Dual Ink Co Axial Bioprinter Translational Research Initiative Cell Engineering 3d Bioprinting Islet Transplantation
Source: uow.edu.au